RMgmDB - Rodent Malaria genetically modified Parasites

Summary

RMgm-392
Malaria parasiteP. berghei
Genotype
DisruptedGene model (rodent): PBANKA_0409400; Gene model (P.falciparum): PF3D7_0311400; Gene product: protein kinase, putative (putative kinase related protein; PKRP)
Phenotype Fertilization and ookinete; Oocyst; Sporozoite; Liver stage;
Last modified: 21 December 2011, 15:27
  *RMgm-392
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Gene disruption
Reference (PubMed-PMID number) Reference 1 (PMID number) : 20227415
MR4 number
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. berghei
Parent strain/lineP. berghei ANKA
Name parent line/clone P. berghei ANKA cl15cy1
Other information parent lineA reference wild type clone from the ANKA strain of P. berghei (PubMed: PMID: 17406255).
The mutant parasite was generated by
Name PI/ResearcherL..A. Purcell; A. Rodriguez
Name Group/DepartmentDepartment of Medical Parasitology
Name InstituteNew York University School of Medicine
CityNew York
CountryUSA
Name of the mutant parasite
RMgm numberRMgm-392
Principal namepkrp-
Alternative name
Standardized name
Is the mutant parasite cloned after genetic modificationYes
Phenotype
Asexual blood stageNot different from wild type
Gametocyte/GameteNot different from wild type
Fertilization and ookineteOokinete formation is reduced. This result is not based on counting ookinetes in vitro or in vivo but on quantitative PCR analysis of levels of 18S rRNA in mosquito midguts.
OocystNumbers of oocyst and of midgut-derived sporozoites are reduced. Transmission electron microscopy analyses of oocysts did not reveal any morphological differences wild type and mutant oocysts.
SporozoiteNumbers of oocyst and of midgut-derived sporozoites are reduced. A reduction (~75%)in the number of salivary gland sporozoites. Salivary gland sporozoites showed normal gliding motility, hepatocyte invasion, liver stage development and infectivity to mice.
Liver stageNumbers of oocyst and of midgut-derived sporozoites are reduced. A reduction (~75%)in the number of salivary gland sporozoites. Salivary gland sporozoites showed normal gliding motility, hepatocyte invasion, liver stage development and infectivity to mice.
Additional remarks phenotype

Mutant/mutation
The mutant lacks expression of a putative kinase related protein (PKRP).

Protein (function)

Phenotype
Phenotype analyses indicate that PKRP plays a role during ookinete/oocyst development. The mutant shows reduced numbers of oocysts and salivary gland sporozoites. However, the protein appears not to be essential for formation of mature oocysts and infective sporozoites.

See also RMgm-520 for an independen mutant lacking expression of PKRP (PBANKA_040940). Phenotype analyses of this mutant showed the following characteristics: Ookinete formation not different from wild type; Oocyst numbers (day12-14) reduced to 50% of wild type; Salivary gland sporozoite numbers reduced to 10% of wild type; No transmission by mosquito bite.

Additional information
Expression data from this gene shows intermediate level expression in sporozoites, low-level expression throughout the asexual stages and highest levels in gametocytes.

The pkrp gene was targeted for complete deletion according to the gene model (PB001650.02.0) which was obtained from PlasmoDB. However, the latest Sanger sequencing and re-annotation effort has revealed that the pkrp ORF is much longer than initially described; the gene has now been re-named PBANKA_040940 (GeneDB). Consequently, this mutant has only part (i.e. N’ terminal deletion) of the ORF removed.

Disruption of the P. falciparum ortholog, PFC0485w, has been reported by Agarwal, S et al. (2011; J Cell Biochem). In this paper no information on the phenotype of mutants with a disrupted PFC0485w gene is provided.

Disruption of the P. falciparum ortholog has been attempted (Solyakov et al., 2011, Nat Commun, 2:565). After transfection with a KO vector a strong PCR signal diagnostic for gene disruption was observed in transfected populations indicating that this gene is not essential for asexual proliferation. Cloning will however be required to validate this interpretation for this

Other mutants
RMgm-520: an independen mutant lacking expression of PKRP (PBANKA_040940)


  Disrupted: Mutant parasite with a disrupted gene
Details of the target gene
Gene Model of Rodent Parasite PBANKA_0409400
Gene Model P. falciparum ortholog PF3D7_0311400
Gene productprotein kinase, putative
Gene product: Alternative nameputative kinase related protein; PKRP
Details of the genetic modification
Inducable system usedNo
Additional remarks inducable system
Type of plasmid/construct usedPlasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid KpnI, SacII
Partial or complete disruption of the genePartial
Additional remarks partial/complete disruption The pkrp gene was targeted for complete deletion according to the gene model (PB001650.02.0) which was obtained from PlasmoDB. However, the latest Sanger sequencing and re-annotation effort has revealed that the pkrp ORF is much longer than initially described; the gene has now been re-named PBANKA_040940 (GeneDB). Consequently, this mutant has only part (i.e. N’ terminal deletion) of the ORF removed.
Selectable marker used to select the mutant parasitetgdhfr
Promoter of the selectable markerpbdhfr
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modification
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1agaaggtacccacatcataataatagcaaactgcac
Additional information primer 1G1FKp (KpnI); 5'target region forward
Sequence Primer 2ttagaagcttttccagacgggttaatatcaaaa
Additional information primer 2G1RH3 (HindIII); 5'target region reverse
Sequence Primer 3ttatggatcctgaaaatagataaaaattcaatcatgg
Additional information primer 3G2FBam (BamHI); 3'target region forward
Sequence Primer 4aaaatctagatttttcacct
Additional information primer 4G2RXb (BamHI); 3'target region reverse
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6